<DOC>
	<DOCNO>NCT01438970</DOCNO>
	<brief_summary>This single centre , prospective , uncontrolled study include 12 consecutive patient cirrhosis liver recurrent refractory ascites . The main aim ( primary objective ) study investigate effect treatment ascites Sequana medical pump renal circulatory function patient cirrhosis recurrent refractory ascites . The secondary objective follow : - To evaluate efficacy treatment handle ascites , associate change body weight patient requirement evacuation paracentesis follow-up . - To investigate effect treatment bacterial translocation , mean determine bacterial DNA . - To determine incidence complication associate treatment course follow-up . - To evaluate effect treatment quality life patient treat , evaluate questionnaire entitle Short Form-36 CLDQ ( chronic liver disease questionnaire ) .</brief_summary>
	<brief_title>Effects Treatment Ascites ALFApump System Renal Circulatory Function</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<criteria>1 . Patients &gt; 18 year age 2 . Cirrhosis liver define histological and/or clinical , analytical radiological criterion . 3 . Presenting refractory recurrent ascites , require 2 evacuation paracentesis procedure last 3 month . 4 . Written inform consent 5 . Ability comply study procedure ability operate device 6 . Women childbearing age use adequate contraceptive 1 . Digestive haemorrhage last 7 day ( patient include 7day period go ) . 2 . Kidney failure define serum creatinine high equal 2 mg/dl . 3 . Serum bilirubin great 5 mg/dl . 4 . Severe coagulopathy define platelet count le 40,000 prothrombin time le 40 % . 5 . Recurring bacterial peritonitis , define 2 episode last 6 month . 6 . Recurring urinary infection , define 2 episode last 6 month . 7 . Clinical evidence loculated ascites . 8 . Advanced hepatocarcinoma , define one exceed Milan criterion . 9 . Previous liver transplant . 10 . Obstructive uropathy bladder anomaly might contraindicate implantation device . 11 . Pregnancy 12 . Patients another clinical study reach primary endpoint yet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>